[1]
“Comparison of Safety and Effectiveness of Bivalirudin Between Diabetic and Nondiabetic Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention”, J Dhaka Med Coll, vol. 31, no. 1, pp. 125–136, May 2023, doi: 10.3329/jdmc.v31i1.65487.